Q2 FY2026 EarningsQ2 FY2026 beat consensus across all key financial metrics, driven by record revenue of $19.9M vs. $17.9M expected and a significantly higher gross margin of 61.3% vs. 57.4% expected. Net loss narrowed by nearly 30% YoY, and GAAP EPS of -$0.13 outperformed the -$0.19 consensus estimate. Management increased full-year revenue guidance to $72M - $75M (from $70M - $73M), reflecting robust demand and strong AVISE CTD test pricing power.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Exagen(XGN) the Revenue is 19.94 M (+15.92%), Beat estimate;the EBIT is -1.722 M (+34.52%), Beat estimate;the EPS is -0.13 (+38.1%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.02B15.92%
0.02B3.88%
+0.00B12.04%
EBITExceed expectations
-0.00B34.52%
-0.00B30.91%
+0.00B65.43%
EPSExceed expectations
-0.1338.10%
-0.19148.84%
+0.061429.26%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf